Lung Biotechnology
Lung Biotechnology PBC is engaged in the research and development, and marketing of therapies for pulmonary arterial hypertension (PAH).
Employees
Recent deals
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Lung Biotechnology
Edit
exited